Biomarker modeling of Alzheimer’s disease using PET-based Braak stagingJoseph Therriault, Pedro Rosa‐Neto, Tharick A. Pascoal et al.|Nature Aging|2022Cited by 300
Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission TomographyJoseph Therriault, Pedro Rosa‐Neto, Kaj Blennow et al.|JAMA Neurology|2022Cited by 261
Comparing tau status determined via plasma pTau181, pTau231 and [18F]MK6240 tau-PETCécile Tissot, Pedro Rosa‐Neto, Joseph Therriault et al.|EBioMedicine|2022Cited by 76
Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer’s disease progressionFilip Liebsch, Gerhard Multhaup, Luka Kulic et al.|Nature Communications|2019Cited by 62
Cryo-EM structure of Alzheimer’s disease tau filaments with PET ligand MK-6240Peter Kunach, Sarah H. Shahmoradian, Jaime Vaquer‐Alicea et al.|Nature Communications|2024Cited by 41